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ABSTRACT 
 
Objectives:  To explore the burden of neonatal sepsis and evaluate a quality 
improvement (QI) project aimed at improving the timing of antibiotics to neonates with 
suspected sepsis at birth.  The goal of the QI project was to identify and minimize 
barriers to antibiotic administration in an effort to improve overall morbidity and 
mortality rates.   
 
Methods:  A retrospective chart review was conducted over a 7-month period for 
infants born at UNC Women’s Hospital and admitted to North Carolina Children’s Critical 
Care Center (NCCC).   For each infant, information was collected regarding time from 
birth to antibiotic order placement, time from order placement to administration of the 
first and second antibiotics, and time from birth to administration of both antibiotics.   
 
Results:  Results were analyzed before and after the June 2015 rollout of a hospital-wide 
Code Sepsis Initiative.  The mean weekly average time from birth to order placement 
stayed the same throughout the project (51 minutes).  Administration time for ampicillin 
improved (51 to 43 minutes), while the administration time for gentamicin remained the 
same (59 minutes).  This resulted in a decreased difference in time between 
administration of gentamicin and ampicillin from 17 minutes to 11 minutes respectfully 
before and after Go-Live.  Further, the total time from birth administration of both 
antibiotics decreased from 122 to 108 minutes overall.   
 
Conclusions:  A step-wise, interdisciplinary approach can work to analyze medication 
administration processes and decrease overall administration time.   
3 
 
Table of Contents 
 
 
Background            4 
Defining the Problem           5 
 Epidemiology            6 
 Treatment           8 
Quality Improvement Project 
 Objective           8 
 Methods           9 
 Results          10 
 Discussion         13 
 Conclusion         19 
References          20 
 
 
4 
 
Background 
Estimating the global burden of sepsis is difficult due to relatively crude 
estimates of the condition in developed countries and a virtual lack of data about rates 
in lesser developed countries (Jawad, Luksic, & Ranfnsson, 2012).  Despite difficulty 
obtaining absolute figures, it is clear that the burden of sepsis is increasing worldwide.  
According to the Centers for Disease Control and Prevention (CDC), the total number of 
hospitalizations in the United States for which sepsis was listed as the primary diagnosis 
rose from 326,000 in 2000 to 816,000 in 2010 (National Center for Health Statistics, 
2010).  Overall hospitalizations did not increase during the same time period, indicating 
that sepsis accounted for a greater percentage of hospitalizations.   
The World Health Organization (WHO) collects data about Global Burden of 
Disease (GBD), which indirectly suggest low-income countries are disproportionally 
affected by sepsis.  Only 1 of the top 10 causes of death in high-income countries is 
categorized as an infectious disease: lower respiratory infections, which kill 31 people 
per 100,000 (World Health Organization, 2012).  In contrast, for low-income countries, 
infectious diseases account for 5 of the top 10 causes of death: lower respiratory 
infections, HIV/AIDS, diarrheal diseases, malaria, and tuberculosis, which kill 275 people 
per 100,000 (World Health Organization, 2012).  Because specific numbers on sepsis are 
not recorded, it is not possible to conclude the percentage of infectious disease deaths 
due to sepsis.  However, given that infection is a necessary precursor to sepsis, the data 
suggest rates of sepsis are likely significantly higher in low-income countries.   
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Around the world, infants and children are at increased risk of contracting 
infectious diseases given their immature immune systems.  The WHO estimated that 6.6 
million children under the age of 5 died in 2012, with prematurity, pneumonia, birth 
asphyxia and birth trauma, and diarrheal illnesses being the most common causes of 
death (World Health Organization, 2012).  Ninety-nine percent of these deaths were in 
low-and-middle-income countries, underscoring the disparity faced by children in lesser 
developed countries (World Health Organization, 2012).  Of the total child deaths, 44% 
occurred during the neonatal period, which is comprised of the first 28 days after birth 
(World Health Organization, 2012).  While addressing disparities and decreasing the 
global burden of sepsis is an important public health concern, this paper will explore the 
clinical challenges of identifying and treating early-onset neonatal sepsis and detail a 
quality improvement project undertaken by a Level IV neonatal intensive care unit 
aimed at improving care to this at-risk population.   
Defining the Problem 
 Neonatal sepsis is broadly defined as a systemic infection occurring in infants 
within the first 28 days of life (Edwards MS, 2004).  It is often divided into early-onset 
sepsis (EOS) and late-onset sepsis (LOS) based upon infant age at the time infection 
begins.  EOS is generally accepted as occurring within the first 3 days of life, while LOS 
typically occurs after day 3 of life.   The distinction becomes clinically important when 
attempting to determine the cause of sepsis, as differing pathogens are more likely to 
cause infection in EOS and LOS.  While the causative agent of EOS is typically 
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transmitted from the mother, LOS is more likely to be caused by a hospital-acquired 
pathogen. 
Early-onset sepsis is most often caused by pathogens from the maternal 
environment with the infant being exposed either in utero or during passage through 
the birth canal.  In term infants Group B Streptococcus (GBS) is the most common cause 
of EOS, while Escherichia coli (E. coli) is the most common cause of EOS in preterm 
infants (Stoll BJ H. N., 2011).  Screening protocols for identification and treatment of 
Group B Streptococcus (GBS) have significantly decreased the incidence of GBS sepsis 
(van den Hoogen A, 2010).  A 2000 study by Schrag et al reported a 65% decrease in the 
incidence of early-onset sepsis between 1993-1998 (Schrag SJ, 2000).  In 1996, 
consensus guidelines were released by the American Academy of Pediatrics, the CDC, 
and the American College of Obstetricians and Gynecologists calling for treatment of 
GBS in high-risk pregnant women to reduce spread of the bacteria to newborns (AAP, 
1997) (CDC, 1996) (ACOG, 1996).  In the Schrag et al study, the steepest decline in GBS 
sepsis occurred shortly after this prophylactic treatment of mothers became routine 
practice.  During this time, the percentage of EOS secondary to E. coli began to increase.  
One NICU reported that for the first time in 40 years E. coli comprised a larger 
percentage of EOS than did GBS (Bizzaro MJ, 2015).  Treatment for E. coli sepsis includes 
administration of antibiotics (primarily ampicillin), however there are no screening 
methods for identifying and treating mothers at risk of passing E. coli to their newborns.  
The picture of EOS in neonates has changed.  With screening and treatment of GBS in 
pregnant mothers, the bacteria causes fewer cases of EOS.  Subsequently, E. coli now 
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accounts for a greater number of EOS cases.  Despite sustained decreases in neonatal 
morbidity from treatment of maternal GBS, EOS continues to be a source of significant 
morbidity and mortality.  Infants diagnosed with neonatal sepsis have an increased risk 
of death and significant complications including brain damage and neurodevelopmental 
delays when compared to neonates who do not become septic (Bakhuizen SE, 2014). 
Epidemiology 
Among all infants, the incidence of culture-confirmed EOS is approximately 0.77-
0.98 cases per 1000 (Weston EJ, 2011) (Stoll BJ H. N., 2011).  However certain groups of 
infants are at increased risk of developing EOS due to either maternal factors, infant 
factors, or a combination of both.  The most common risk factors are listed below in 
Table 1. 
Table 1: Maternal and Infant Risk Factors for Neonatal Sepsis 
Maternal Risk Factors Infant Risk Factors 
 Chorioamnionitis  Preterm birth 
 Prolonged rupture of membranes 
>18 hours 
 Low birth weight 
 Fever during labor (>38C)  Congenital anomalies  
 Vaginal colonization with GBS  Instrument-assisted delivery 
 Procedures during pregnancy  Apgar score < 6 at 5 minutes 
 
Prematurity and low birth weight are especially important risk factors that significantly 
increase the chance of developing sepsis in neonates.  A neonate is considered 
premature if it is born prior to completion of 37 weeks gestation.  Low birth weight is 
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defined as less than 2500 grams, regardless of gestational age.  Important subcategories 
relevant to this discussion include very low birth weight (VLBW), which is less than 1500 
grams, and extremely low birth weight (ELBW), less than 1000 grams.  The incidence of 
EOS is higher in VLBW infants, with rates reported between 15-19 per 1000 (Stoll BJ H. 
N., 2005) (Stoll BJ G. T., 1996).  Further, while EOS is associated with increased short-
term and long-term sequel, these risks are magnified for smaller neonates.  A study by 
the National Institute of Child Health and Human Development Neonatal Research 
Network showed that ELBW infants who were diagnosed with neonatal sepsis were 
more likely to suffer neurodevelopmental deficits than those ELBW infants who were 
not septic (Stoll BJ H. N.-C., 2004).  
Treatment 
 The treatment of sepsis requires a complex set of evaluations and clinical 
decision making far beyond the scope of this paper.  Treatment is tailored to individual 
patients; however, there are mainstays of sepsis management that have been proven to 
improve morbidity and mortality.   The 3rd edition of “Surviving Sepsis Campaign:  
International Guidelines for Management of Severe Sepsis and Septic Shock” was 
released in 2012 (Dellinger RP, 2012) .  This was an update to the 2008 clinical practice 
guidelines and provides evidence-based information for the diagnosis and treatment of 
sepsis.    Guidelines for management of newborn septic shock by the American College 
of Critical Care Medicine outline goals for the first hour of sepsis treatment (Brierley J, 
2009).  These goals are:  maintain airway, oxygenation, and ventilation; restore and 
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maintain circulation, correct hypoglycemia and hypocalcemia, begin antibiotics, and 
begin prostaglandin until ductal-dependent lesion is ruled out (Brierley J, 2009). 
Quality Improvement Project 
Objective 
 The objective of the quality improvement (QI) project was to identify strategies 
to improve administration of antibiotics to neonates admitted to the neonatal intensive 
care unit (NICU) directly after birth.  This NICU QI project was undertaken as part of 
larger hospital-wide “Code Sepsis” campaign by UNC Health Care to decrease raw 
mortality from sepsis 10% by June 2016 as compared to a baseline rate from 2013.   
Methods 
 The quality improvement project took place at North Carolina’s Children’s 
Hospital’s Newborn Critical Care Center (NCCC), a 58-bed level IV neonatal intensive 
care unit.  The NCCC cares for approximately 800 infants each year.  Data were collected 
retrospectively from the electronic medical record for infants admitted to the NCCC 
between February 2015 and October 2015.  Infants were included in the study if they 
were admitted to the NICU immediately after birth and were deemed to either be septic 
at birth or require a “rule-out sepsis” workup upon admission.  Infants admitted to the 
NICU who did not meet these sepsis requirements at birth were not included.  Likewise, 
infants who received antibiotics immediately after birth, but were not admitted to the 
NICU were not included our analysis.  For each neonate, data collected included time 
and date of birth, time of initial antibiotic order, time of administration of the first 
antibiotic, and time of administration of the second antibiotic.  In addition, the 
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admission note was reviewed to assess clinical decision making and to clarify 
discrepancies in data recording.  From the information collected, five parameters were 
calculated for each patient: 1) time from birth to order placement, 2) time from order to 
administration of the ampicillin, 3) difference between administration of gentamicin and 
ampicillin, 4) time from order to administration of gentamicin, and 5) time from birth to 
administration of both antibiotics.  QI Macros, an add-on feature of Microsoft Excel, was 
used to generate control charts to analyze the data. 
Results 
 During the project period, 174 neonates were included over a total of 27 weeks.   
An interdisciplinary exploration of current antibiotic administration procedures at 
inception of the project revealed several target areas for improving efficiency.  First, 
providers were not consistently placing the order for antibiotics immediately after birth.  
Once the order was placed, nurses were not prioritizing administering antibiotics over 
other medications or tasks.  Finally, there was noted to be a delay in pharmacy 
distribution of antibiotics.  Plans were devised to address these three bottlenecks.  
Education was provided to nursing staff and providers regarding the importance of 
prioritizing antibiotic administration during the admission of neonates who were 
suspected of sepsis.  This education occurred on March 13, 2015.  The NCCC team also 
collaborated with pharmacy to improve workflow for the delivery of antibiotics.  This 
new workflow called for a STAT antibiotic order and subsequent phone call to the 
pediatric pharmacy to alert them to the new STAT order.  
Birth to Order Placement 
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 The first parameter in the antibiotic administration pathway is placement of the 
order.  The control chart (Figure 1) shows that with the exception of two weeks 
(8/23/15 and 8/30/15) the variation observed between the average weekly times in 
birth to order placement were within the upper and lower control limits, indicating 
process is stable overall.  Starting with the week of 6/7/15, a process change is 
illustrated on the graph.  This is the first week after the Children’s Hospital Go Live of 
the hospital-wide Code Sepsis initiative.  The interval between the upper and lower 
control limits decreased after that time, however the mean weekly time remained the 
same (51 minutes) before and after the Go-Live event.   
Figure 1: Control Chart for Birth to Order Placement 
 
 
Order Placement to Administration of Ampicillin 
 Figure 2 shows the control chart for time to administration of ampicillin.  With 
the exception of weeks 9/6/15 and 9/13/15, the process appears stable.  The graph 
indicates a process change the week of 6/7/15, when the Children’s Hospital Go Live of 
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the hospital-wide Code Sepsis initiative was implemented.  After this, there was a 
decrease in the upper control limit for the process and a change in the average 
administration time from 51 to 43 minutes. 
Figure 2: Control Chart for Time to Administration of Ampicillin 
 
 
Order Placement to Administration of Gentamicin 
 Average time from order to administration of gentamicin was 59 minutes prior 
to initiation of the Code Sepsis initiative (6/7/15) and was unchanged after this date.  
However, the confidence interval decreased, suggesting tighter control of the overall 
process. 
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Figure 3: Control Chart for Time to Administration of Gentamicin 
 
 
Difference between Time of Administration of Gentamicin and Ampicillin 
  The difference in administration time between gentamicin and ampicillin was 
calculated in an effort to explore if there was significant delay in administering 
gentamicin, which is routinely given after ampicillin.  Results showed that prior to the 
Go-Live date of 6/7/15, there was an average of 17 minutes difference between 
administration of ampicillin and subsequent administration of gentamicin.  This 
decreased to 11 minutes after 6/7/15. 
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Figure 4: Control Chart for Average Time between Gentamicin and Ampicillin 
Administration 
 
Birth to Administration of Both Antibiotics 
 When examining the overall process, there was a decrease in length of time for 
the entire process after the Go-Live of Code Sepsis (6/7/15) as compared with before 
the event.  The average time from birth to administration of both antibiotics decreased 
from 122 minutes before 6/7/15 to 108 after. 
Figure 5: Control Chart for Average Time from Birth to Administration of Both 
Antibiotics  
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Discussion 
Overall, the results provide a mixed picture.  The mean weekly average time 
from birth to order placement stayed the same throughout the project (51 minutes).  
Administration time for ampicillin improved (51 to 43 minutes), while the administration 
time for gentamicin remained the same (59 minutes).  This resulted in a decreased 
difference in time between administration of gentamicin and ampicillin.  Further, the 
total time from birth administration of both antibiotics decreased from 122 to 108 
minutes overall.   
At the onset of the study, an interdisciplinary team including physicians, nurses, 
pharmacists, and front desk staff were included in discussions regarding bottlenecks in 
medication administration.  On March 13, 2015 providers and staff underwent relevant 
education to address identified needs in the medication administration pathway.  
Physician education reinforced the concept that antibiotics should be ordered STAT on 
admission when a neonate was considered at risk for sepsis.  Nurse education 
underscored the importance of administering antibiotics prior to other medications or 
required duties.  A new protocol for ordering antibiotics also involved calling pharmacy 
after placement of a STAT computer order for antibiotics to prompt acknowledgement 
of the medication order.  Further, front desk staff were trained to recognize STAT 
medication orders arriving from pharmacy and ensure swift delivery of medications to 
the appropriate location. 
Average time to administration of ampicillin decreased from 51 minutes to 43 
minutes after the hospital-wide Go-Live of Code Sepsis.  As part of the project 
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education, nurses were instructed to prioritize administration of antibiotics over other 
tasks.  Further, ampicillin storage policy changed, and the medication started being 
stored in the NICU.  This allowed nurses to override the medication order and 
administer the drug prior to pharmacy acknowledgement.   
There was not a significant change in time to administration of gentamicin after 
the Go-Live event.  To assess if pharmacy acknowledgement and release of medication 
orders served as a bottleneck, we assessed the change in the time differences between 
administration of gentamicin and ampicillin.  Before the Go-Live date, there was an 
average difference of approximately 17 minutes between administration of the two 
medications, while afterwards this value decreased to 11 minutes.  This indicates the 
new workflow, which included decreasing the time taken to obtain gentamicin from the 
pharmacy, helped to improve antibiotic administration time overall.  It is unclear, 
however, why this was the case given the mean time to gentamicin administration 
remained the same.  This may be attributed to a heightened sense among the nurses 
that both antibiotics need to be given promptly.  Continued monitoring of the data and 
further dissecting the antibiotic administration pathway are necessary to help clarify 
these findings.  Though there are no set guidelines for an acceptable amount of time 
between administration of the two antibiotics, a suggested target time was less than 10 
minutes.  Several weeks after the Go-Live event were able to achieve this target.   
Perhaps the most important result overall was the decrease in time from birth to 
administration of both antibiotics.  This represents the entirety of the individual 
processes previously discussed.  There was improvement in the overall process from 122 
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minutes prior to the Go-Live to 108 minutes afterward.  Again, because there were only 
3 baseline data points, it is somewhat difficult to assess how representative these weeks 
were of the actual baseline prior to education of providers and staff.  In addition, 
consensus regarding target time for administration of antibiotics from birth is unclear.  
There is talk of the golden hour after diagnosis of sepsis, however neonates provide 
unique challenges in creation of an electronic health record, obtaining access for 
administration of antibiotics, and the potential for resuscitation and stabilization prior 
to administration of medications.  While the mean weekly average of 108 minutes does 
not approach the 60 minutes in the golden hour, it does represent a significant 
improvement over the 122 minute average prior to the Go-Live event.    
Based on observed results during this QI project, changes in practice were 
implemented.  A provider pocket card was created for physicians detailing the proper 
workflow when ordering a septic evaluation for an infant.  The steps involved a STAT 
order of antibiotics, followed by a call to the pediatric pharmacy to alert them of the 
new stat order.  Also included on the card were the antibiotics used in a neonatal sepsis 
evaluation along with proper dosing guidelines.  After several weeks of following these 
steps, monitoring of the new process revealed there was no longer a need for a follow-
up phone call to pharmacy.  STAT orders placed in the electronic medical record were 
quickly acknowledged and acted upon by pharmacy.  Efforts are underway with the 
electronic medical record to further streamline the order placement process.  Currently, 
a sepsis evaluation order set is embedded in the NICU admission order set, which is a 
lengthy series of admission orders.  In the future there will ideally be an option for 
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providers to complete a more streamlined admission order set for newborns requiring a 
sepsis evaluation on admission.  Important, but less time-sensitive admission orders can 
be completed in a follow-up separate order set.   
Another outcome of this quality improvement project is the Small Baby Protocol.  
One of the bottlenecks identified in the antibiotic administration pathway occurred 
despite prompt placement of orders, pharmacy acknowledgement and delivery of 
medication.  There were still delays in administration of medications because line 
placement conformation was delayed while awaiting x-ray technicians to perform 
imaging.  This was addressed by implementing a text page to the x-ray technician with 
the placement of a STAT order for a chest x-ray to confirm line placement.  This new 
step in the antibiotic administration pathway was a direct result of undertaking this 
quality improvement project.    
 A limitation of a retrospective quality improvement study such as this one is that 
it can be very difficult to decipher from the electronic medical record the actual course 
of events that lead to treatment or non-treatment.  Particularly in the case of identifying 
newborns at risk for sepsis, there is a significant amount of clinical decision making left 
to the individual provider.  There is the possibility that some newborns who should have 
been identified as at risk for sepsis were not labeled as such by the covering provider.  
Further, because this study took place in a teaching hospital, the plan documented by 
the fellow may differ from the initial plan documented by the attending in some cases.   
 Ideally, there would have been a longer period of baseline data prior to the 
education of providers and staff.  Education was administered after only 3 weeks of data 
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were collected.  More information prior to the education intervention may have made it 
easier to appreciate whether the educational efforts actually worked to improve 
antibiotic administration times.  For this reason, the hospital-wide Go-Live of Code 
Sepsis served as a process change by which to reassess data.  With the adoption of this 
initiative, there was a push from all stakeholders to decrease mortality from sepsis.  
While these data suggest a decrease in the amount of time elapsed between birth and 
administration of both antibiotics necessary for treatment of sepsis in neonates, 
continued monitoring and evaluation are needed to maintain and continue 
improvement in the process of antibiotic delivery.   
Conclusion 
  Treating sepsis effectively requires more than quickly administering antibiotics.  
However, efficient administration of antibiotics is a key step in the process of rendering 
quality care to neonates at risk of sepsis.  The results of this study indicate that a 
stepwise approach to evaluating the process by which antibiotics are administered can 
help identify areas for improvement.  
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